News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,475 Results
Type
Article (63114)
Company Profile (442)
Press Release (663919)
Multimedia
Podcasts (111)
Webinars (13)
Section
Business (194617)
Career Advice (3411)
Deals (35158)
Drug Delivery (128)
Drug Development (85182)
Employer Resources (182)
FDA (17378)
Job Trends (15202)
News (343055)
Policy (35782)
Tag
Academia (2948)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (95)
Alliances (50444)
ALS (106)
Alzheimer's disease (1500)
Antibody-drug conjugate (ADC) (163)
Approvals (17332)
Artificial intelligence (305)
Autoimmune disease (29)
Automation (17)
Bankruptcy (370)
Best Places to Work (11850)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (325)
Bladder cancer (86)
Brain cancer (31)
Breast cancer (313)
Cancer (2482)
Cardiovascular disease (208)
Career advice (2888)
Career pathing (33)
CAR-T (182)
Cell therapy (506)
Cervical cancer (22)
Clinical research (68951)
Collaboration (933)
Company closure (2)
Compensation (592)
Complete response letters (30)
COVID-19 (2842)
CRISPR (50)
C-suite (274)
Cystic fibrosis (110)
Data (2397)
Decentralized trials (2)
Denatured (34)
Depression (55)
Diabetes (298)
Diagnostics (6599)
Digital health (20)
Diversity (6)
Diversity, equity & inclusion (46)
Drug discovery (139)
Drug pricing (133)
Drug shortages (33)
Duchenne muscular dystrophy (106)
Earnings (75763)
Editorial (47)
Employer branding (22)
Employer resources (157)
Events (117505)
Executive appointments (773)
FDA (18813)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (832)
Gene editing (125)
Generative AI (27)
Gene therapy (373)
GLP-1 (855)
Government (4972)
Grass and pollen (6)
Guidances (164)
Healthcare (19845)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (156)
Indications (30)
Infectious disease (3004)
Inflammatory bowel disease (158)
Inflation Reduction Act (12)
Influenza (58)
Intellectual property (104)
Interviews (662)
IPO (16630)
IRA (51)
Job creations (3805)
Job search strategy (2363)
Kidney cancer (11)
Labor market (43)
Layoffs (551)
Leadership (23)
Legal (8533)
Liver cancer (82)
Lung cancer (346)
Lymphoma (163)
Machine learning (9)
Management (62)
Manufacturing (368)
MASH (85)
Medical device (13826)
Medtech (13829)
Mergers & acquisitions (19126)
Metabolic disorders (804)
Multiple sclerosis (89)
NASH (23)
Neurodegenerative disease (120)
Neuropsychiatric disorders (34)
Neuroscience (2130)
NextGen: Class of 2025 (7037)
Non-profit (4831)
Now hiring (34)
Obesity (433)
Opinion (272)
Ovarian cancer (84)
Pain (105)
Pancreatic cancer (89)
Parkinson's disease (167)
Partnered (21)
Patents (261)
Patient recruitment (120)
Peanut (51)
People (57349)
Pharmaceutical (87)
Pharmacy benefit managers (24)
Phase I (21406)
Phase II (30198)
Phase III (22804)
Pipeline (1466)
Policy (181)
Postmarket research (2893)
Preclinical (9303)
Press Release (69)
Prostate cancer (115)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (438)
Real estate (6115)
Recruiting (71)
Regulatory (24637)
Reports (45)
Research institute (2617)
Resumes & cover letters (543)
Rett syndrome (6)
RNA editing (5)
RSV (49)
Schizophrenia (84)
Series A (145)
Series B (98)
Service/supplier (13)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (159)
Sponsored (34)
Startups (3708)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (58)
The Weekly (76)
Vaccines (816)
Venture capitalists (45)
Weight loss (304)
Women's health (39)
Worklife (20)
Date
Today (163)
Last 7 days (1043)
Last 30 days (3472)
Last 365 days (34373)
2025 (12849)
2024 (37012)
2023 (41641)
2022 (52832)
2021 (57445)
2020 (55782)
2019 (48569)
2018 (36862)
2017 (34904)
2016 (34814)
2015 (39967)
2014 (33008)
2013 (27889)
2012 (29738)
2011 (29995)
2010 (28001)
Location
Africa (1020)
Alabama (60)
Alaska (7)
Arizona (230)
Arkansas (14)
Asia (43143)
Australia (7516)
California (6629)
Canada (2077)
China (577)
Colorado (285)
Connecticut (305)
Delaware (163)
Europe (99828)
Florida (982)
Georgia (222)
Hawaii (1)
Idaho (60)
Illinois (595)
India (27)
Indiana (317)
Iowa (12)
Japan (176)
Kansas (108)
Kentucky (27)
Louisiana (13)
Maine (71)
Maryland (978)
Massachusetts (5104)
Michigan (238)
Minnesota (411)
Mississippi (1)
Missouri (84)
Montana (28)
Nebraska (21)
Nevada (64)
New Hampshire (69)
New Jersey (1865)
New Mexico (31)
New York (1871)
North Carolina (1106)
North Dakota (9)
Northern California (2914)
Ohio (217)
Oklahoma (15)
Oregon (37)
Pennsylvania (1460)
Puerto Rico (13)
Rhode Island (32)
South America (1396)
South Carolina (26)
South Dakota (1)
Southern California (2470)
Tennessee (104)
Texas (980)
United States (25158)
Utah (197)
Virginia (161)
Washington D.C. (70)
Washington State (601)
West Virginia (3)
Wisconsin (69)
727,475 Results for "the parkinson s institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neurodegenerative disease
Inhibikase Scraps Parkinson’s Drug After Disappointing Mid-Stage Data
Inhibikase’s setback continues biopharma’s losing streak against Parkinson’s, marked by several clinical failures and abandoned assets in recent months.
January 30, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Theralase(R) Therapy Improves Motor and Non-Motor Function in Parkinson’s Patients
Parkinson’s Patients Have Improved Motor and Non-Motor Function After Treatment with Theralase(R) Cool Laser Therapy
March 10, 2025
·
12 min read
Parkinson’s disease
Roche’s Prothena-Partnered Parkinson’s Drug Fails Mid-Stage Trial
The report comes just two days after Novartis announced its own Parkinson’s drug failure.
December 19, 2024
·
1 min read
·
Annalee Armstrong
Press Releases
Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
May 12, 2025
·
6 min read
Press Releases
ATED Therapeutics, Ltd.: New Rapid, Simple Blood Test for Parkinson’s Disease Developed
April 14, 2025
·
2 min read
Neurodegenerative disease
7 Alzheimer’s and Parkinson’s Programs Discarded in 2024
This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are still chasing these multi-billion-dollar markets.
November 4, 2024
·
6 min read
·
Heather McKenzie
Press Releases
Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
April 30, 2025
·
5 min read
Press Releases
TreeFrog Therapeutics Presents Delivery Strategy for Next Generation 3D Cell Therapy Format for Parkinson’s Disease at the 28th Annual ASGCT Meeting in New Orleans
May 13, 2025
·
3 min read
Press Releases
ZyVersa Therapeutics Announces Published Data Showing Inflammasome ASC Inhibitor IC 100 Decreases Microglial Inflammasome Activation and Alpha-Synuclein That Contribute to Neurodegeneration in Parkinson’s Disease
April 30, 2025
·
7 min read
Press Releases
First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s disease
May 13, 2025
·
7 min read
1 of 72,748
Next
